The following is a brief overview of clinical trial data available to date
Microdosing semaglutide in units Microdosing has gained attention as an approach for people who are extremely sensitive to GLP-1 side effects or who want to start even more conservatively than the standard 0.25mg initiation dose
doi: 10.1111/dme.13160 67 SteinbergWMRosenstockJWaddenTADonsmarkMJensenCBDeVriesJH
Review the result itself, the direction of change, the size of the change, associated symptoms, and the timing relative to medication initiation or dose escalation
Dyspepsia (indigestion) and abdominal discomfort are also documented in the SmPC
By using a portable pen injector, such as the semaglutide pen, which is professionally designed for at-home use and safe to handle, patients can enjoy an added layer of safety and security